Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
Background Kallistatin exerts beneficial effects on organ injury by inhibiting oxidative stress and inflammation. However, the role of kallistatin in atherosclerosis is largely unknown. Here, we investigated the role and mechanisms of kallistatin in patients with coronary artery disease (CAD), ather...
Main Authors: | Yuyu Yao, Bing Li, Chang Liu, Cong Fu, Pengfei Li, Youming Guo, Genshan Ma, Naifeng Liu, Lee Chao, Julie Chao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-11-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.118.009562 |
Similar Items
-
Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells
by: Fauziyya Muhammad, et al.
Published: (2020-05-01) -
Evaluation of Serum Kallistatin Levels in Women with Preeclampsia and its Role in Assessing Preeclampsia Severity
by: Rangeen Badri Mahdi, et al.
Published: (2024-12-01) -
Role of kallistatin in pediatric patients with pulmonary arterial hypertension
by: Özge Pamukçu, et al.
Published: (2020-06-01) -
Kallistatin leads to cognition impairment via downregulating glutamine synthetase
by: Yanlan Long, et al.
Published: (2024-04-01) -
Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
by: Zhiyun Cheng, et al.
Published: (2015-05-01)